Ribo partners with Boehringer Ingelheim to develop new treatments for people with liver diseases
INGELHEIM, Germany, MÖLNDAL, Sweden and KUNSHAN, China, Jan. 3, 2024 /PRNewswire/ — Suzhou Ribo Life Science Co., Ltd. and Ribocure AB (Ribo) today announced a collaboration with Boehringer Ingelheim to develop novel treatments for nonalcoholic or metabolic dysfunction-associated steatohepat
Healthcare holds its own amid a tepid deal market, reaching $444 billion in 2023
Bain & Company’s Global Healthcare Private Equity and M&A report shows how AI and innovative new therapies, such as GLP-1s, are transforming the investment landscape NEW YORK, Jan. 3, 2024 /PRNewswire/ — The healthcare sector continued to be a hub of private equity (PE) deal acti
6th CAMS Continuing Airworthiness Management Live Summit, 15th March 2024 – Understanding Regulatory Structures and CAMO Approval Processes
DUBLIN, Jan. 3, 2024 /PRNewswire/ — The “6th CAMS Continuing Airworthiness Management Summit” has been added to ResearchAndMarkets.com’s offering. This major event will offer the opportunity to discuss Continuing Airworthiness Management which is widely used with more opera
VAPORESSO Sets New Record with Over 130 Awards in 2023
SHENZHEN, China, Jan. 3, 2024 /PRNewswire/ — VAPORESSO, a leading innovator in the vaping industry, has achieved a historic milestone in 2023 by winning over 130 international and authoritative awards from a number of industrial organizations and media outlets, highlighting the brand’s
OKX Ventures Report Highlights USDC and USDT Domination with 90%+ of Evolving Stablecoin Market
Stablecoins poised to revolutionize global payments, emphasizing the need for enhanced integration SINGAPORE, Jan. 3, 2024 /PRNewswire/ — OKX Ventures, the investment arm of leading Web3 technology company OKX, today released a detailed report on the current state and future prospects of the s
Diamond Lake Minerals, Inc. Announces Tree-Planting Partnership with Evertreen
SALT LAKE CITY, Jan. 3, 2024 /PRNewswire/ — Diamond Lake Minerals, Inc. (OTC: DLMI) is as a leading player in the digital asset landscape, bridging the gap between traditional finance and decentralized finance (DeFi). Their mission aligns with the development and support of digital assets and
Belief BioMed Successfully Completed Dosing of First Subject in the Registrational Clinical Trial for Hemophilia A
SHANGHAI, Jan. 3, 2024 /PRNewswire/ — Belief BioMed Group (BBM), an industry-leading biotech company focusing on innovative gene therapies, announced the completion of first subject dosing in its registrational clinical trial (CTR20233400) of BBM-H803, a gene therapy for hemophilia A, independ
SmartCella strengthens team by recruiting Dr. Nina Bauer as Chief Business Officer
STOCKHOLM, Jan. 3, 2024 /PRNewswire/ — SmartCella Holding AB today announces that Dr. Nina Bauer, MBA, has been appointed Chief Business Officer and Head of Smartwise. Nina Bauer joins in January 2024 from MilliporeSigma, where she most recently held the role of Global Head of Commercial, Vira
Global Digital Genome Market Set to Hit US$ 92.93 Bn by 2030, Growing at 19.58% CAGR, with North America Leading the Market Driven by Advancements in DNA Sequencing Technologies, States Kings Research
DUBAI, UAE, Jan. 3, 2024 /PRNewswire/ — As per the recent report released by Kings Research, the global Digital Genome Market revenue was recorded at USD 22.22 billion in 2022 and is likely to reach USD 92.93 billion by 2030, growing at a 19.58% CAGR from 2023 to 2030. Numerous pivotal factors
Product Estimation and Should-Cost Analysis Leader Galorath Appoints Three New Executives to Support Next Wave of Expansion and Growth
New Additions Bring Diverse Expertise to Industry-Leader in Transforming Cost, Scheduling, Should-Cost Analysis, and Project Estimation LONG BEACH, Calif., Jan. 3, 2024 /PRNewswire/ — Today, Galorath, the premier provider of cost, scheduling and should-cost estimation solutions and consulting
